ADMA - Company ID 0001368514
ADMA BIOLOGICS, INC. (ADMA) reported revenue of $510.17M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $510.17M | +19.6% |
| FY 2024 | $426.45M | +65.2% |
| FY 2023 | $258.21M | +67.6% |
| FY 2022 | $154.08M | +90.4% |
| FY 2021 | $80.94M | +91.7% |
| FY 2020 | $42.22M | +43.9% |
| FY 2019 | $29.35M | +72.8% |
| FY 2018 | $16.99M | -25.4% |
| FY 2017 |
ADMA BIOLOGICS, INC. (ADMA) reported revenue of $510.17M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, ADMA BIOLOGICS, INC.'s revenue grew from $761.04K to $510.17M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $22.76M |
| +113.5% |
| FY 2016 | $10.66M | +48.5% |
| FY 2015 | $7.18M | +21.3% |
| FY 2014 | $5.92M | +92.8% |
| FY 2013 | $3.07M | +174.4% |
| FY 2012 | $1.12M | +46.9% |
| FY 2011 | $761.04K | - |